Skip to content

A prospective study of Kupffer phase whole liver scan in screening liver metastases

A prospective study of Kupffer phase whole liver scan in screening liver metastases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054385
Enrollment
Unknown
Registered
2021-12-16
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver metastases

Interventions

Gold Standard:Enhanced MRI examination
Index test:Kupffer&#32

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. History of malignant tumors prone to liver metastases (known or unknown liver metastases, mainly non-upper abdominal malignant tumors); 2. Have done or plan to undergo enhanced MRI within two months; 3. Sign the informed consent; 4. Aged 18 to 75 years; 5. Enhanced CT examination before or within 2 months after contrast-enhanced ultrasound (optional).

Exclusion criteria

Exclusion criteria: 1. Patients with liver metastases after local treatment such as ablation or TACE; 2. Patients with a history of protein allergy or any type of ultrasound contrast agent allergy; 3. Pregnant or lactating women; 4. Severe heart disease, hypertension, severe liver and kidney dysfunction; 5. Poor lung function; 6. Other situations that are not suitable for ultrasound examination or enhanced CT/MRI examination.

Design outcomes

Primary

MeasureTime frame
diagnostic accuracy;

Countries

China

Contacts

Public ContactLi Yi

Shanghai Sixth People's Hospital

yannanfly@126.com+86 18930173144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026